Australia's most trusted
source of pharma news
Tuesday, 19 May 2026
Posted 19 May 2026 PM
Gilead Sciences has been named the World’s Most Innovative Pharma, for developing the HIV prophylaxis Yeztugo and introducing it into Africa in the same year as its US FDA approval.
“This pharma company’s twice-yearly shot is putting the end of HIV/AIDS within reach,” wrote Fast Company, which put Gilead at the top of its most innovative medicine, therapeutics and pharmaceutical companies list of 2026.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.